Details for Patent: 8,106,183
✉ Email this page to a colleague
Which drugs does patent 8,106,183 protect, and when does it expire?
Patent 8,106,183 protects LEXISCAN and is included in one NDA.
This patent has twenty-eight patent family members in eighteen countries.
Summary for Patent: 8,106,183
Title: | Process for preparing an A.sub.2A-adenosine receptor agonist and its polymorphs |
Abstract: | Disclosed is a synthesis suitable for large scale manufacture of an A.sub.2A-adenosine receptor agonist, and also relates to polymorphs of that compound, and to methods of isolating a specific polymorph. |
Inventor(s): | Zablocki; Jeff (Mountain View, CA), Elzein; Elfaith (Fremont, CA) |
Assignee: | Gilead Sciences, Inc. (Foster City, CA) |
Application Number: | 12/765,623 |
Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for patent 8,106,183 |
Patent Claim Types: see list of patent claims | Compound; Use; Process; |
Drugs Protected by US Patent 8,106,183
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Astellas | LEXISCAN | regadenoson | SOLUTION;INTRAVENOUS | 022161-001 | Apr 10, 2008 | AP | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | Y | ⤷ Sign Up | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 8,106,183
Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
---|---|---|---|---|---|
Australia | 2007212542 | ⤷ Sign Up | |||
Canada | 2640089 | ⤷ Sign Up | |||
Canada | 2787759 | ⤷ Sign Up | |||
China | 101379073 | ⤷ Sign Up | |||
China | 102260311 | ⤷ Sign Up | |||
European Patent Office | 1989214 | ⤷ Sign Up | |||
>Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |